ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

123
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
29 May 2024 21:57

SciClone Pharma (6600 HK): Scheme Vote on 19 June

SciClone has received a letter of support from Pentwater Capital Management to vote YES. Pentwater represents 4.64% of out. shares and 8.51% of...

Logo
846 Views
Share
bullishL'Occitane
27 May 2024 00:18

Merger Arb Mondays (27 May) - L'Occitane, SciClone, GA Pack, KFC Japan, CF Logistics, Best World

This week, the highest gross spreads are HEC Pharma (107.6%), Hollysys (19.3%), Ansarada (13.1%), Malaysia Airports (9.6%), China TCM (8.7%),...

Logo
497 Views
Share
bullishEoflow
26 May 2024 07:00

Last Week in Event SPACE: Mitsui Matsushima, L'Occitane, Prosus/Tencent, EOFlow

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
598 Views
Share
bullishBHP Group Ltd
25 May 2024 15:00

(Mostly) Asia-Pac M&A: KFC Holdings Japan, Shanghai Henlius, Alumina, BHP/ Anglo American, SciClone

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
689 Views
Share
23 May 2024 14:40

Henlius Biotech (2696 HK): Fosun Offer?

IF Fosun wants to take the company private, an Offer Price of $26/share, may get the job done. $30/share would be optically be more preferable.

Logo
441 Views
Share
x